Experienced in Intestinal Pseudo-Obstruction

Dr. Don C. Rockey

Hepatology | Gastroenterology
University Medical Associates Of The Medical University Of South Carol
171 Ashley Ave, 
Charleston, SC 
Accepting New Patients
Offers Telehealth
Experienced in Intestinal Pseudo-Obstruction
University Medical Associates Of The Medical University Of South Carol
171 Ashley Ave, 
Charleston, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Don Rockey is a Hepatologist and a Gastroenterologist in Charleston, South Carolina. Dr. Rockey is rated as an Experienced provider by MediFind in the treatment of Intestinal Pseudo-Obstruction. His top areas of expertise are Gastrointestinal Bleeding, Portal Hypertension, Cirrhosis, Endoscopy, and Colonoscopy. Dr. Rockey is currently accepting new patients.

His clinical research consists of co-authoring 361 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Intestinal Pseudo-Obstruction.

Specialties
Hepatology
Gastroenterology
Licenses
Internal Medicine in SC
Hospital Affiliations
Musc Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
View 1 Less Insurance Carrier -

Locations

UNIVERSITY MEDICAL ASSOCIATES OF THE MEDICAL UNIVERSITY OF SOUTH CAROL
171 Ashley Ave, Charleston, SC 29425

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Enrollment Status: Active_not_recruiting
Publish Date: April 11, 2025
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Safety and Efficacy of Ifetroban for the Treatment of Portal Hypertension in Cirrhotic Patients
A Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Safety and Efficacy of Ifetroban for the Treatment of Portal Hypertension in Cirrhotic Patients
Enrollment Status: Completed
Publish Date: January 19, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
A Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
Enrollment Status: Terminated
Publish Date: November 18, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
Enrollment Status: Withdrawn
Publish Date: June 14, 2018
Intervention Type: Dietary supplement, Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

355 Total Publications

Resmetirom and thyroid hormone receptor-targeted treatment for metabolic dysfunction-associated steatotic liver disease (MASLD).
Resmetirom and thyroid hormone receptor-targeted treatment for metabolic dysfunction-associated steatotic liver disease (MASLD).
Journal: Portal hypertension & cirrhosis
Published: August 08, 2025
Similar Doctors
Experienced in Intestinal Pseudo-Obstruction
Dr. Caitlin Green
Gastroenterology
Experienced in Intestinal Pseudo-Obstruction
Dr. Caitlin Green
Gastroenterology

University Medical Associates Of The Medical University Of South Carol

171 Ashley Ave, 
Charleston, SC 
 (0.1 miles away)
843-792-1414
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Caitlin Green is a Gastroenterologist in Charleston, South Carolina. Dr. Green is rated as an Advanced provider by MediFind in the treatment of Intestinal Pseudo-Obstruction. Her top areas of expertise are Gastroparesis, Gastric Dysmotility, Eosinophilic Enteropathy, Gastrectomy, and Colonoscopy.

Experienced in Intestinal Pseudo-Obstruction
Dr. Amol Sharma
Gastroenterology
Experienced in Intestinal Pseudo-Obstruction
Dr. Amol Sharma
Gastroenterology

University Medical Associates Of The Medical University Of South Carol

2060 Sam Rittenberg Blvd, 
Charleston, SC 
 (4.9 miles away)
843-792-1414
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Amol Sharma is a Gastroenterologist in Charleston, South Carolina. Dr. Sharma is rated as a Distinguished provider by MediFind in the treatment of Intestinal Pseudo-Obstruction. His top areas of expertise are Bowel Incontinence, Chronic Idiopathic Constipation (CIC), Gastroparesis, Endoscopy, and Gastrostomy.

Experienced in Intestinal Pseudo-Obstruction
Dr. Andrew S. Brock
Gastroenterology
Experienced in Intestinal Pseudo-Obstruction
Dr. Andrew S. Brock
Gastroenterology

University Medical Associates Of The Medical University Of South Carol

171 Ashley Ave, 
Charleston, SC 
 (0.1 miles away)
843-792-1414
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Brock is a Gastroenterologist in Charleston, South Carolina. Dr. Brock is rated as an Advanced provider by MediFind in the treatment of Intestinal Pseudo-Obstruction. His top areas of expertise are Angiodysplasia of the Colon, Trichohepatoenteric Syndrome, Crohn's Disease, Endoscopy, and Gastrostomy. Dr. Brock is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rockey's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile